GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

 1,435.40p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,674.40p
  • 52 Week Low: 1,190.80p
  • Currency: UK Pounds
  • Shares Issued: 5,032m
  • Volume: 0
  • Market Cap: 72,222m
  • RiskGrade: 129

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart (17-06-2021)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.6% 5.7%
Div Cover 1.4 1.2
Op Mrgn 22.8% 21.8%
ROCE 66.0%  
Latest F'cast
P/E 12.4 14.4
PEG n/a n/a
Pr/Revenue 2.1 2.1
Pr/Book 3.5  
Latest F'cast
Revenue 1.0% -3.0%
PBT 12.0% 3.4%
EPS -6.5% -15.9%
DPS n/a -0.6%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%
31-Dec-20 34,099.00 6,968.00 115.90p 11.6 n/a -6% 80.00p 6.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 33,087.56 7,204.29 97.42p 14.7 n/a -16% 79.56p 5.7%
31-Dec-22 34,905.70 7,928.71 108.46p 13.2 1.2 +11% 58.07p 4.1%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

GSK and iTeos announce collaboration for EOS-448 14-Jun-2021 11:58 RNS
Director/PDMR Shareholding 11-Jun-2021 16:54 RNS
Director/PDMR Shareholding 09-Jun-2021 15:28 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
09-Jun-21 Transfer From Emma Walmsley 0.000p 9 0.00
09-Jun-21 Buy Emma Walmsley 1,361.95p 9 122.58
07-Jun-21 Buy Dividends Hal Barron 1,937.50p 2,390 46,303.62

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,435.40p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,674.40p
52 Week Low 1,190.80p
Volume 0
Shares Issued 5,032m
Market Cap 72,222m
RiskGrade 129

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.97% above the market average90.97% above the market average90.97% above the market average90.97% above the market average90.97% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
66.98% below the market average66.98% below the market average66.98% below the market average66.98% below the market average66.98% below the market average
69.49% below the sector average69.49% below the sector average69.49% below the sector average69.49% below the sector average69.49% below the sector average
Income
91.47% above the market average91.47% above the market average91.47% above the market average91.47% above the market average91.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
46.56% above the market average46.56% above the market average46.56% above the market average46.56% above the market average46.56% above the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average

What The Brokers Say

Strong Buy 8
Buy 1
Neutral 14
Sell 0
Strong Sell 3
Total 26
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Q4
Ex-Div 20-May-21 18-Feb-21
Paid 08-Jul-21 08-Apr-21
Amount 19.00p 23.00p

Trades for --2021

Time Volume / Share Price
0 @ 0.000p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page